2014 International Meeting on the Molecular Biology of Hepatitis B Viruses
2014年乙型肝炎病毒分子生物学国际会议
基本信息
- 批准号:8712000
- 负责人:
- 金额:$ 0.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAntiviral TherapyBasic ScienceBiochemistryBiologyBiomedical ResearchCaliforniaCellular biologyCessation of lifeCirrhosisCommunitiesDevelopmentDiabetes MellitusDigestive System DisordersDisciplineDiseaseFinancial SupportFoundationsFund RaisingFundingGene ExpressionGoalsGrantHepatitis BHepatitis B VirusHepatitis Delta VirusHome environmentImmunologyIndividualInfectionInstitutesInternationalJointsKidney DiseasesKnowledgeLightLiver FailureLos AngelesMalignant NeoplasmsMinorityMissionModalityMolecular BiologyNational Cancer InstituteNational Institute of Allergy and Infectious DiseaseNational Institute of General Medical SciencesOralPathogenesisPopulationPostdoctoral FellowPrimary carcinoma of the liver cellsPublic HealthRNA EditingRegulatory ElementResearchResearch PersonnelScheduleScientistSenior ScientistSeriesStructureTherapeuticTimeTravelUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVaccinesViralVirusVirus DiseasesVirus Sheddingcostgene therapygraduate studentinterestlecturermeetingspathogenpostersprophylacticprotein expressionpublic health relevancesymposiumvectorvirology
项目摘要
Project Summary
This proposal is a request for funding to support the travel expenses for young scientists to
attend and participate in the 2014 International Meeting on the Molecular Biology of Hepatitis B
Viruses, scheduled for September 3 - 6, 2014 at the conference facility of the University of
California, Los Angeles. This meeting is the only forum that gathers the international community
of researchers that focus on the hepatitis B virus (HBV) and the closely associated hepatitis
delta virus (HDV). Approximately 25% of the world's population has been infected by HBV.
Unfortunately, despite the availability of prophylactic vaccines, many new infections occur
worldwide, mostly because of underutilization of the vaccine due to cost and other issues.
Moreover, for the approximately 350 million people already chronically infected with HBV
(approximately 15 million of whom are co-infected with HDV), the vaccine is of no therapeutic
value. As a result, between 0.5 and 1 million people die of HBV/HDV every year worldwide. It is
therefore imperative that basic research on HBV continues, and the latest progress in the field is
discussed and disseminated in a timely manner. The annual HBV meeting provides the forum
for scientific exchanges and the dissemination of latest research information. The 2014 meeting
will uphold and enhance the traditional format. It will consist of 9 oral scientific sessions and 2
poster sessions as well as less structured "networking" time. The scientific interactions will be
facilitated by two keynote addresses. As in the past, great effort has been made to minimize the
cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to
support this meeting since 2005, in terms of providing a permanent home for organizing the
meeting and making its staff available for organizing the meeting and publicizing it, especially to
universities with large numbers of underrepresented minorities. In order to allow the
participation of junior and minority investigators, support from the NIH to help defray the meeting
costs is requested.
项目概要
该提案是一项资金请求,以支持年轻科学家的旅费
出席并参加2014年乙型肝炎分子生物学国际会议
病毒,定于 2014 年 9 月 3 日至 6 日在大学会议设施举行
加利福尼亚州、洛杉矶。这次会议是唯一一个聚集国际社会的论坛
专注于乙型肝炎病毒 (HBV) 和密切相关的肝炎的研究人员
δ病毒(HDV)。世界上大约25%的人口感染过乙型肝炎病毒。
不幸的是,尽管有预防性疫苗,但仍然出现了许多新的感染
在世界范围内,主要是由于成本和其他问题导致疫苗利用不足。
此外,对于已经慢性感染乙肝病毒的大约 3.5 亿人来说
(其中约 1500 万人同时感染丁型肝炎病毒),该疫苗没有治疗作用
价值。因此,全世界每年有 0.5 至 100 万人死于 HBV/HDV。这是
因此,继续进行乙型肝炎的基础研究势在必行,该领域的最新进展
并及时进行讨论和传播。一年一度的 HBV 会议提供了论坛
用于科学交流和传播最新研究信息。 2014年会议
将秉承并发扬传统形式。它将包括 9 场口头科学会议和 2 场
海报会议以及结构性较低的“社交”时间。科学的互动将是
两位主旨演讲推动了会议的进行。与过去一样,我们付出了巨大的努力来尽量减少
会议费用。此外,乙型肝炎基金会做出了坚定承诺
自 2005 年以来一直支持本次会议,为组织这次会议提供永久场所
会议并让其工作人员能够组织会议并进行宣传,特别是向
拥有大量代表性不足的少数族裔的大学。为了让
初级和少数族裔研究人员的参与,NIH 的支持以帮助支付会议费用
要求费用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J.-H. James Ou其他文献
J.-H. James Ou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J.-H. James Ou', 18)}}的其他基金
Autophagy and the Replication of Hepatitis B Virus
自噬和乙型肝炎病毒的复制
- 批准号:
10094192 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Autophagy and the Replication of Hepatitis B Virus
自噬和乙型肝炎病毒的复制
- 批准号:
10334474 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Autophagy and the Replication of Hepatitis B Virus
自噬和乙型肝炎病毒的复制
- 批准号:
10549790 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Hepatitis B virus e antigen in viral persistence
乙型肝炎病毒e抗原在病毒持续存在中
- 批准号:
10159091 - 财政年份:2017
- 资助金额:
$ 0.6万 - 项目类别:
Hepatitis B virus e antigen in viral persistence
乙型肝炎病毒e抗原在病毒持续存在中
- 批准号:
9402258 - 财政年份:2017
- 资助金额:
$ 0.6万 - 项目类别:
Hepatitis B virus e antigen in viral persistence
乙型肝炎病毒e抗原在病毒持续存在中
- 批准号:
10650689 - 财政年份:2017
- 资助金额:
$ 0.6万 - 项目类别:
HBV replication and persistence in mouse models
小鼠模型中的 HBV 复制和持久性
- 批准号:
8598634 - 财政年份:2013
- 资助金额:
$ 0.6万 - 项目类别:
HBV replication and persistence in mouse models
小鼠模型中的 HBV 复制和持久性
- 批准号:
8719097 - 财政年份:2013
- 资助金额:
$ 0.6万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists